Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 78 companies made new 52-week lows.
This Analyst Boosts PT On PepsiCo? Plus UBS Sees $75 For Micron Technology
Deutsche Bank raised the price target on PepsiCo, Inc. (NASDAQ: PEP) from $179 to $181. Deutsche Bank analyst Steve Powers maintained a Hold rating on the stock. PepsiCo shares fell 1.2% to $166.47 on Tuesday.
Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket
Gainers
9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for Vurolenatide in short bowel syndrome.
9 Meters Biopharma Q2 EPS $(0.04) Down From $(0.03) YoY
9 Meters Biopharma (NASDAQ:NMTR) reported quarterly losses of $(0.04) per share. This is a 33.33 percent decrease over losses of $(0.03) per share from the same period last year.
Around $2 Million Bet On This Stock? 4 Penny Stocks Insiders are Buying
The US economy added 372,000 payrolls in June, following a revised 384,000 growth in May. Investors, meanwhile, focused on some notable insider trades.
Maxim Group Downgrades 9 Meters Biopharma to Hold
Maxim Group analyst Jason McCarthy downgrades 9 Meters Biopharma (NASDAQ:NMTR) from Buy to Hold.
Akerna Shares Dip 53%, Here’s 78 Biggest Movers From Yesterday
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.